vs
Side-by-side financial comparison of Credo Technology Group Holding Ltd (CRDO) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Credo Technology Group Holding Ltd is the larger business by last-quarter revenue ($268.0M vs $168.4M, roughly 1.6× Esperion Therapeutics, Inc.). On growth, Credo Technology Group Holding Ltd posted the faster year-over-year revenue change (272.1% vs 143.7%). Over the past eight quarters, Credo Technology Group Holding Ltd's revenue compounded faster (124.8% CAGR vs 10.6%).
Seiko Group is a corporate group composed of Seiko Group Corporation and its subsidiaries and affiliates. It used to be recognized as a corporate group consisting of three core companies Seiko Holdings Corp., Seiko Instruments Inc., and Seiko Epson Corp. The three companies were linked by a common thread of timepiece technology. Although Epson still develops and manufactures wristwatches for the Seiko Group, Epson and its subsidiaries are not considered part of the group.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CRDO vs ESPR — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $268.0M | $168.4M |
| Net Profit | $82.6M | — |
| Gross Margin | 67.5% | — |
| Operating Margin | 29.4% | 50.6% |
| Net Margin | 30.8% | — |
| Revenue YoY | 272.1% | 143.7% |
| Net Profit YoY | 2055.9% | — |
| EPS (diluted) | $0.44 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $268.0M | $168.4M | ||
| Q3 25 | $223.1M | $87.3M | ||
| Q2 25 | $170.0M | $82.4M | ||
| Q1 25 | $135.0M | $65.0M | ||
| Q4 24 | $72.0M | $69.1M | ||
| Q3 24 | $59.7M | $51.6M | ||
| Q2 24 | $60.8M | $73.8M | ||
| Q1 24 | $53.1M | $137.7M |
| Q4 25 | $82.6M | — | ||
| Q3 25 | $63.4M | $-31.3M | ||
| Q2 25 | $36.6M | $-12.7M | ||
| Q1 25 | $29.4M | $-40.5M | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-9.5M | $-29.5M | ||
| Q2 24 | $-10.5M | $-61.9M | ||
| Q1 24 | $428.0K | $61.0M |
| Q4 25 | 67.5% | — | ||
| Q3 25 | 67.4% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 63.6% | — | ||
| Q4 24 | 63.2% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 65.8% | — | ||
| Q1 24 | 61.4% | — |
| Q4 25 | 29.4% | 50.6% | ||
| Q3 25 | 27.2% | -11.4% | ||
| Q2 25 | 19.9% | 8.6% | ||
| Q1 25 | 19.4% | -34.0% | ||
| Q4 24 | -11.7% | -6.4% | ||
| Q3 24 | -24.2% | -31.0% | ||
| Q2 24 | -13.0% | 3.5% | ||
| Q1 24 | -11.1% | 52.5% |
| Q4 25 | 30.8% | — | ||
| Q3 25 | 28.4% | -35.9% | ||
| Q2 25 | 21.5% | -15.4% | ||
| Q1 25 | 21.7% | -62.2% | ||
| Q4 24 | -5.9% | — | ||
| Q3 24 | -16.0% | -57.2% | ||
| Q2 24 | -17.2% | -83.9% | ||
| Q1 24 | 0.8% | 44.3% |
| Q4 25 | $0.44 | $0.32 | ||
| Q3 25 | $0.34 | $-0.16 | ||
| Q2 25 | $0.22 | $-0.06 | ||
| Q1 25 | $0.16 | $-0.21 | ||
| Q4 24 | $-0.03 | $-0.14 | ||
| Q3 24 | $-0.06 | $-0.15 | ||
| Q2 24 | $-0.06 | $-0.33 | ||
| Q1 24 | $0.00 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $813.6M | $167.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $-302.0M |
| Total Assets | $1.4B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $813.6M | $167.9M | ||
| Q3 25 | $479.6M | $92.4M | ||
| Q2 25 | $431.3M | $86.1M | ||
| Q1 25 | $379.2M | $114.6M | ||
| Q4 24 | $383.0M | $144.8M | ||
| Q3 24 | $398.6M | $144.7M | ||
| Q2 24 | $410.0M | $189.3M | ||
| Q1 24 | $409.1M | $226.6M |
| Q4 25 | $1.3B | $-302.0M | ||
| Q3 25 | $781.4M | $-451.4M | ||
| Q2 25 | $681.6M | $-433.5M | ||
| Q1 25 | $618.2M | $-426.2M | ||
| Q4 24 | $567.9M | $-388.7M | ||
| Q3 24 | $553.1M | $-370.2M | ||
| Q2 24 | $540.2M | $-344.2M | ||
| Q1 24 | $534.0M | $-294.3M |
| Q4 25 | $1.4B | $465.9M | ||
| Q3 25 | $905.2M | $364.0M | ||
| Q2 25 | $809.3M | $347.1M | ||
| Q1 25 | $719.9M | $324.0M | ||
| Q4 24 | $638.6M | $343.8M | ||
| Q3 24 | $644.9M | $314.1M | ||
| Q2 24 | $601.9M | $352.3M | ||
| Q1 24 | $592.5M | $373.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.7M | $45.2M |
| Free Cash FlowOCF − Capex | $38.5M | — |
| FCF MarginFCF / Revenue | 14.4% | — |
| Capex IntensityCapex / Revenue | 8.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.75× | — |
| TTM Free Cash FlowTrailing 4 quarters | $143.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.7M | $45.2M | ||
| Q3 25 | $54.2M | $-4.3M | ||
| Q2 25 | $57.8M | $-31.4M | ||
| Q1 25 | $4.2M | $-22.6M | ||
| Q4 24 | $10.3M | $-35.0M | ||
| Q3 24 | $-7.2M | $-35.3M | ||
| Q2 24 | $4.2M | $-7.2M | ||
| Q1 24 | $-1.0M | $53.8M |
| Q4 25 | $38.5M | — | ||
| Q3 25 | $51.3M | — | ||
| Q2 25 | $54.2M | — | ||
| Q1 25 | $-383.0K | — | ||
| Q4 24 | $-11.7M | — | ||
| Q3 24 | $-13.1M | $-35.5M | ||
| Q2 24 | $962.0K | $-7.3M | ||
| Q1 24 | $-6.1M | $53.8M |
| Q4 25 | 14.4% | — | ||
| Q3 25 | 23.0% | — | ||
| Q2 25 | 31.9% | — | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -16.2% | — | ||
| Q3 24 | -21.9% | -68.7% | ||
| Q2 24 | 1.6% | -9.9% | ||
| Q1 24 | -11.6% | 39.0% |
| Q4 25 | 8.7% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 2.1% | 0.0% | ||
| Q1 25 | 3.4% | 0.0% | ||
| Q4 24 | 30.5% | 0.0% | ||
| Q3 24 | 9.8% | 0.3% | ||
| Q2 24 | 5.3% | 0.1% | ||
| Q1 24 | 9.6% | 0.1% |
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.42× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRDO
| Other | $132.1M | 49% |
| HK | $104.4M | 39% |
| RESTOFTHEWORLD | $31.5M | 12% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
